Shares of Life Technologies (NASDAQ: LIFE) jumped in January, when the company announced it was looking for a potential buyer, and it may now be close to a decision, with solid offers having come in both from Blackstone Group (BX) and Thermo Fisher Scientific (TMO 0.01%). What will this biotech decide, and how will it affect investors? In this video, Motley Fool health-care analyst David Williamson gives us a breakdown of the offers on the table, and how investors could be affected depending on the outcome.
And the Bidding War Winner Is ...
By Dave Williamson
-
Apr 10, 2013 at 6:41PM
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Who's going to win the bidding war over Life Technologies, and will it pay off big for investors?
Stocks Mentioned

Illumina, Inc.
ILMN
$245.07
(0.65%)
$1.58

The Blackstone Group L.P.
BX

Danaher Corporation
DHR
$253.12
(0.52%)
$1.32

Thermo Fisher Scientific Inc.
TMO
$555.21
(0.01%)
$0.06
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles

Why Moderna and Pfizer Stocks Lagged the Market Today

Why Johnson & Johnson Stock Is Rising Today

Why Emergent BioSolutions Stock Is Jumping Today

Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?

3 High-Yield Dividend Stocks You'll Never Have to Sell
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.